This is a synthetic peptide designed for use in combination with anti-C20ORF20 antibody (Catalog #: ARP33351_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
MRGBP
(MRG-Binding Protein (MRGBP))
Hintergrund
C20orf20 is a component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair.
Alias Symbols: Eaf7, MRGBP, URCC4, MRG15BP, C20ORF20
Protein Interaction Partner: ACTB,ACTL6A,BRD8,DMAP1,ING1,MEAF6,MORF4L1,MORF4L2,RUVBL1,TRRAP,TUBB,YEATS4,BRD8